Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs00027743
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
ZY4![]() | N-[(1S)-1-BENZYL-2,2-DIHYDROXY- 3-(TETRAHYDRO-2H-PYRAN-4-YLAMINO)PROPYL]- 6-ETHYL-1-METHYL-1,3,4,6-TETRAHYDRO[1,2]THIAZEPINO[5,4,3- CD]INDOLE-8-CARBOXAMIDE 2,2-DIOXIDE | A | 2WF4 | 0.7 | ![]() |
PMY![]() | AGLYCON OF PEPLOMYCIN | A | 1AO4 | 0.72 | ![]() |
PMY![]() | AGLYCON OF PEPLOMYCIN | A | 1AO2 | 0.72 | ![]() |
XV6![]() | A | 1BV9 | 0.74 | ![]() | |
XV6![]() | B | 1BWA | 0.74 | ![]() | |
XV6![]() | A | 1BV7 | 0.74 | ![]() | |
XV6![]() | A | 1QBR | 0.74 | ![]() | |
GPB![]() | N-[4-[2-(2-AMINO-4-METHYL-7H-PYRROLO[2,3- D]PYRIMIDIN-5-YL)-ETHYL]-BENZOYL]GLUTAMIC ACID | A | 1E26 | 0.71 | ![]() |
BTH![]() | 4-OXO-3-{6-[4-(QUINOXALIN-2-YLAMINO)- BENZOYLAMINO]-2-THIOPHEN-2-YL-HEXANOYLAMINO}- PENTANOIC ACID | A | 1RWO | 0.72 | ![]() |
PL1![]() | COBALT (III)-DEGLYCOPEPLEOMYCIN | B | 1AO1 | 0.72 | ![]() |
MZ7![]() | N~2~-ACETYL-N-{(1S,2R)-3-[(1,3- BENZOTHIAZOL-6-YLSULFONYL)(PENTYL)AMINO]- 1-BENZYL-2-HYDROXYPROPYL}-L-VALINAMIDE | A,B | 2QI5 | 0.71 | ![]() |
MZ5![]() | (2S)-N-[(1S,2R)-3-{(1,3-BENZOTHIAZOL- 6-YLSULFONYL)[(2S)-2-METHYLBUTYL]AMINO}- 1-BENZYL-2-HYDROXYPROPYL]-2-HYDROXY- 3-METHYLBUTANAMIDE | A,B | 2QI3 | 0.72 | ![]() |
MZ8![]() | N-{(1S,2R)-3-[(1,3-BENZOTHIAZOL- 6-YLSULFONYL)(ISOBUTYL)AMINO]-1- BENZYL-2-HYDROXYPROPYL}-3-HYDROXYBENZAMIDE | A,B | 2QI6 | 0.72 | ![]() |
PF3![]() | (2R)-3-({[4-[(PYRIDIN-4-YL)PHENYL]- THIEN-2-YL}CARBOXAMIDO)(PHENYL)PROPANOIC ACID | A,B | 1UTZ | 0.71 | ![]() |
304![]() | N-[2-methyl-5-(methylcarbamoyl)phenyl]- 2-{[(1R)-1-methylpropyl]amino}- 1,3-thiazole-5-carboxamide | A | 3BX5 | 0.73 | ![]() |
L1A![]() | N-(MORPHOLIN-4-YLSULFONYL)-L-PHENYLALANYL- 3-(2-AMINO-1,3-THIAZOL-4-YL)-N- {(1R,2R,3S)-1-[(1R)-CYCLOHEX-3- EN-1-YLMETHYL]-2,3-DIHYDROXY-5- METHYLHEXYL}-L-ALANINAMIDE | A,B | 2G20 | 0.74 | ![]() |
846![]() | [4R--(1ALPHA,5ALPHA,7BETA)]-3-[(CYCLOPROPHYLMETHYL)HEXAHYDRO- 5,6-DIHYDROXY-2-OXO-4,7-BIS(PHENYLMETHYL)- 1H-1,3-DIAZEPIN]METHYL-2-THIAZOLYLBENZAMIDE | B | 1QBU | 0.76 | ![]() |
GK6![]() | N-{4'-[(cyclopropylmethyl)carbamoyl]- 6-methylbiphenyl-3-yl}-2-morpholin- 4-ylpyridine-4-carboxamide | A | 3D83 | 0.72 | ![]() |
MZ6![]() | N-[(1S,2R)-3-{(1,3-BENZOTHIAZOL- 6-YLSULFONYL)[(2S)-2-METHYLBUTYL]AMINO}- 1-BENZYL-2-HYDROXYPROPYL]-3-HYDROXYBENZAMIDE | A,B | 2QI4 | 0.72 | ![]() |
B18![]() | (4R)-N-[4-({[2-(DIMETHYLAMINO)ETHYL]AMINO}CARBONYL)- 1,3-THIAZOL-2-YL]-4-METHYL-1-OXO- 2,3,4,9-TETRAHYDRO-1H-BETA-CARBOLINE- 6-CARBOXAMIDE | A,B,C | 2PZY | 0.73 | ![]() |
Q2Y![]() | 4-OXO-3-[2-(5-{[4-(QUINOXALIN-2- YLAMINO)-BENZOYLAMINO]-METHYL}- THIOPHEN-2-YL)-ACETYLAMINO]-PENTANOIC ACID | A | 1RWM | 0.72 | ![]() |
RIT![]() | RITONAVIR | A,B | 2B60 | 0.71 | ![]() |
RIT![]() | RITONAVIR | B,D | 1N49 | 0.71 | ![]() |
RIT![]() | RITONAVIR | A | 1RL8 | 0.71 | ![]() |
RIT![]() | RITONAVIR | B | 1SH9 | 0.71 | ![]() |
RIT![]() | RITONAVIR | B | 1HXW | 0.71 | ![]() |
T42![]() | MORPHOLINO-DIPHENYLALANINE-METHOXYPROPYLBORONIC ACID | H,I | 1AI8 | 0.74 | ![]() |
685![]() | 2-{2-[(3,5-dimethylphenyl)amino]pyrimidin- 4-yl}-N-[(1S)-2-hydroxy-1-methylethyl]- 4-methyl-1,3-thiazole-5-carboxamide | A | 3EMG | 0.77 | ![]() |